[HTML][HTML] Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health
J Denissen, B Reyneke, M Waso-Reyneke… - International journal of …, 2022 - Elsevier
Abstract The ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) …
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) …
Epidemiology of β-lactamase-producing pathogens
K Bush, PA Bradford - Clinical microbiology reviews, 2020 - Am Soc Microbiol
SUMMARY β-Lactam antibiotics have been widely used as therapeutic agents for the past
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design
G Bahr, LJ Gonzalez, AJ Vila - Chemical Reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …
spread of genes coding for resistance determinants among bacteria challenges the use of …
Quaternary ammonium salts: Insights into synthesis and new directions in antibacterial applications
Z Zhou, S Zhou, X Zhang, S Zeng, Y Xu… - Bioconjugate …, 2023 - ACS Publications
The overuse of antibiotics has led to the emergence of a large number of antibiotic-resistant
genes in bacteria, and increasing evidence indicates that a fungicide with an antibacterial …
genes in bacteria, and increasing evidence indicates that a fungicide with an antibacterial …
[HTML][HTML] Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies
Given the spasmodic increment in antimicrobial resistance (AMR), world is on the verge of
“post-antibiotic era”. It is anticipated that current SARS-CoV2 pandemic would worsen the …
“post-antibiotic era”. It is anticipated that current SARS-CoV2 pandemic would worsen the …
Third-generation sequencing in the clinical laboratory: exploring the advantages and challenges of nanopore sequencing
LM Petersen, IW Martin, WE Moschetti… - Journal of clinical …, 2019 - Am Soc Microbiol
Metagenomic sequencing for infectious disease diagnostics is an important tool that holds
promise for use in the clinical laboratory. Challenges for implementation so far include high …
promise for use in the clinical laboratory. Challenges for implementation so far include high …
[HTML][HTML] Fighting antibiotic resistance in hospital-acquired infections: current state and emerging technologies in disease prevention, diagnostics and therapy
E Avershina, V Shapovalova, G Shipulin - Frontiers in microbiology, 2021 - frontiersin.org
Rising antibiotic resistance is a global threat that is projected to cause more deaths than all
cancers combined by 2050. In this review, we set to summarize the current state of antibiotic …
cancers combined by 2050. In this review, we set to summarize the current state of antibiotic …
[HTML][HTML] The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria
D Hammoudi Halat, C Ayoub Moubareck - Antibiotics, 2020 - mdpi.com
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …
Epidemiology of carbapenem-resistant Gram-negative infections globally
AJ Brink - Current opinion in infectious diseases, 2019 - journals.lww.com
High-resistance rates in carbapenem-resistant GNB in many countries will inevitably
complicate treatment of serious infections in vulnerable patient groups and should …
complicate treatment of serious infections in vulnerable patient groups and should …
[HTML][HTML] Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an …
The management of carbapenem-resistant infections is often based on polymyxins,
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …